Actimed Therapeutics Ltd, the clinical stage company, announces that it has been granted a United States patent for ACM-001 (S-pindolol) for treating muscle weakness and a Canadian patent for ACM-002 (S-oxprenolol) for treating amyotrophic lateral sclerosis (ALS).
Bayshore Pharms` Generic Pindolol Receives Approval in US
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?
Nostrum Labs` Generic Pindolol approved in US for Hypertension